Proteolysis and antigen presentation by MHC class II molecules
- PMID: 12078484
- PMCID: PMC7130937
- DOI: 10.1016/s0065-2776(02)80013-x
Proteolysis and antigen presentation by MHC class II molecules
Abstract
Proteolysis is the primary mechanism used by all cells not only to dispose of unwanted proteins but also to regulate protein function and maintain cellular homeostasis. Proteases that reside in the endocytic pathway are the principal actors of terminal protein degradation. The proteases contained in the endocytic pathway are classified into four major groups based on the active-site amino acid used by the enzyme to hydrolyze amide bonds of proteins: cysteine, aspartyl, serine, and metalloproteases. The presentation of peptide antigens by major histocompatibility complex (MHC) class II molecules is strictly dependent on the action of proteases. Class II molecules scour the endocytic pathway for antigenic peptides to bind and present at the cell surface for recognition by CD4+ T cells. The specialized cell types that support antigen presentation by class II molecules are commonly referred to as professional antigen presenting cells (APCs), which include bone marrow-derived B lymphocytes, dendritic cells (DCs), and macrophages. In addition, the expression of certain endocytic proteases is regulated either at the level of gene transcription or enzyme maturation and their activity is controlled by the presence of endogenous protease inhibitors.
Similar articles
-
Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation.Semin Cell Dev Biol. 2000 Jun;11(3):203-10. doi: 10.1006/scdb.2000.0162. Semin Cell Dev Biol. 2000. PMID: 10906277 Review.
-
Proteases, processing, and thymic selection.Science. 1998 Apr 17;280(5362):394-5. doi: 10.1126/science.280.5362.394. Science. 1998. PMID: 9575085 No abstract available.
-
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.J Immunol. 2005 Jun 1;174(11):7066-74. doi: 10.4049/jimmunol.174.11.7066. J Immunol. 2005. PMID: 15905550
-
Lysosomal cysteine proteases and antigen presentation.Ernst Schering Res Found Workshop. 2006;(56):81-95. doi: 10.1007/3-540-37673-9_5. Ernst Schering Res Found Workshop. 2006. PMID: 16329647 Review.
-
Another twist to MHC-peptide recognition.Science. 1996 May 17;272(5264):973-4. doi: 10.1126/science.272.5264.973. Science. 1996. PMID: 8638141 Review. No abstract available.
Cited by
-
Components of the antigen processing and presentation pathway revealed by gene expression microarray analysis following B cell antigen receptor (BCR) stimulation.BMC Bioinformatics. 2006 May 2;7:237. doi: 10.1186/1471-2105-7-237. BMC Bioinformatics. 2006. PMID: 16670020 Free PMC article.
-
Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis.Clin Exp Immunol. 2010 Nov;162(2):298-305. doi: 10.1111/j.1365-2249.2010.04220.x. Epub 2010 Aug 20. Clin Exp Immunol. 2010. PMID: 20731673 Free PMC article.
-
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.Clin Exp Immunol. 2006 Oct;146(1):169-80. doi: 10.1111/j.1365-2249.2006.03188.x. Clin Exp Immunol. 2006. PMID: 16968411 Free PMC article.
-
HIV-1-Infected CD4+ T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing.J Immunol. 2022 Sep 1;209(5):864-873. doi: 10.4049/jimmunol.2200145. Epub 2022 Aug 5. J Immunol. 2022. PMID: 36130133 Free PMC article.
-
The many roads to cross-presentation.J Exp Med. 2005 Nov 21;202(10):1313-8. doi: 10.1084/jem.20051379. Epub 2005 Nov 14. J Exp Med. 2005. PMID: 16287713 Free PMC article. Review.
References
-
- Alfonso C, Karlsson L. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 2000;18:113–142. - PubMed
-
- Alvarez-Fernandez M, Barrett A.J, Gerhartz B, Dando P.M, Ni J, Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 1999;274:19195–19203. - PubMed
-
- Amigorena S, Bonnerot C. Fc receptor signaling and trafficking: A connection for antigen processing. Immunol. Rev. 1999;172:279–284. - PubMed
-
- Amigorena S, Bonnerot C. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.Semin. Semin. Immunol. 1999;11:385–390. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous